Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1-Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00460382
What this trial is testing

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 103
Early research (Phase 1)Study completedNCT00613249
What this trial is testing

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

Who this might be right for
HIV Infections
International Partnership for Microbicides, Inc. 36
Not applicableStudy completedNCT05405582
What this trial is testing

Thetha Nami Ngithethe Nawe ("Let's Talk"): Step Wedge cRCT of Peer Led Community PrEP and SRH for Youth in South Africa

Who this might be right for
HIV-1-infectionSexually Transmitted Diseases
Africa Health Research Institute 8,716
Not applicableStudy completedNCT00351442
What this trial is testing

Examining Factors That May Influence Resistance to HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 522
Testing effectiveness (Phase 2)Study completedNCT00380159
What this trial is testing

Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A

Who this might be right for
Human Immunodeficiency Virus (HIV)-1 Infection
Alexion Pharmaceuticals, Inc. 4
Not applicableUnknownNCT05372510
What this trial is testing

Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.

Who this might be right for
Acute Human Immunodeficiency Virus Type I Infection
MRC/UVRI and LSHTM Uganda Research Unit 100
Early research (Phase 1)Study completedNCT06031272
What this trial is testing

Pausing Antiretroviral Treatment Under Structured Evaluation

Who this might be right for
HIV-1-infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 32
Large-scale testing (Phase 3)Study completedNCT00670839
What this trial is testing

Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)

Who this might be right for
Hepatitis BHIV Infection
ANRS, Emerging Infectious Diseases 178
Not applicableLooking for participantsNCT05136703
What this trial is testing

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

Who this might be right for
DepressionHIV-1-infectionInflammation
Florida International University 150
Early research (Phase 1)Study completedNCT00000777
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancyHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Ended earlyNCT00195312
What this trial is testing

Study Evaluating Vaccine in Adults With HIV

Who this might be right for
HIV Infections
Wyeth is now a wholly owned subsidiary of Pfizer 91
Early research (Phase 1)Active Not RecruitingNCT07055451
What this trial is testing

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV

Who this might be right for
HIV-1-infection
Gilead Sciences 16
Testing effectiveness (Phase 2)Study completedNCT00530777
What this trial is testing

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding

Who this might be right for
HIV InfectionsHerpes Simplex
University of Washington 148
Early research (Phase 1)Study completedNCT00000901
What this trial is testing

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00002218
What this trial is testing

A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients

Who this might be right for
HIV Infections
Parke-Davis 40
Testing effectiveness (Phase 2)Study completedNCT00002324
What this trial is testing

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

Who this might be right for
HIV Infections
Boehringer Ingelheim 250
Large-scale testing (Phase 3)Study completedNCT02345226
What this trial is testing

Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 881
Early research (Phase 1)Study completedNCT01950325
What this trial is testing

VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...

Who this might be right for
HIV-1 InfectionNeutralizing AntibodyMonoclonal Antibody+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT01543958
What this trial is testing

Sevelamer for Reducing Endotoxemia and Immune Activation

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 40
Testing effectiveness (Phase 2)Study completedNCT00299338
What this trial is testing

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

Who this might be right for
HIV Infections
Samaritan Pharmaceuticals, Inc 24
Next Page